References
- Alunno A, Gerli R, Giacomelli R, et al. Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis. Biomed Res Int. 2017;2017(3):1–8.
- Park JH, Park EK, Koo DW, et al. Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2017;18(1):152.
- Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316–1322.
- Shimizu T, Cruz A, Tanaka M, et al. Structural changes over a short period are associated with functional assessments in rheumatoid arthritis. J Rheumatol. 2019;46(7):676–684.
- Zhang MF, Zhao Y, Jiang KY, et al. Comparative pharmacokinetics study of sinomenine in rats after oral administration of sinomenine monomer and Sinomenium acutum extract. Molecules. 2014;19(8):12065–12077.
- Zhao XX, Peng C, Zhang H, et al. Sinomenium acutum: a review of chemistry, pharmacology, pharmacokinetics, and clinical use. Pharm Biol. 2012;50(8):1053–1061.
- Xu M, Liu L, Qi C, et al. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med. 2008;74(12):1423–1429.
- Lin XJ, Hang H, Jin SG, et al. Preparation and in vitro release of sinomenine hydrochloride-loaded chitosan nanoparticles. Chin J Exp Trad Med Formulae. 2011;17(4):22–25.
- Phan S, Fong WK, Kirby N, et al. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421(1):176–182.
- Mishraki T, Ottaviani MF, Shames AI, et al. Structural effects of insulin-loading into HII mesophases monitored by electron paramagnetic resonance (EPR), small angle X-ray spectroscopy (SAXS), and attenuated total reflection Fourier transform spectroscopy (ATR-FTIR). J Phys Chem B. 2011;115(25):8054–8062.
- Mishraki-Berkowitz T, Aserin A, Garti N. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase. J Colloid Interface Sci. 2017;486:184–193.
- Wang X, Zhang Y, Huang J, et al. A novel phytantriol-based lyotropic liquid crystalline gel for efficient ophthalmic delivery of pilocarpine nitrate. AAPS PharmSciTech. 2019;20(1):32.
- Jiang X, Liang X, Wang S, et al. An injectable in situ hexagonal mesophase system for local delivery of minocycline hydrochloride: preparation and pharmacodynamics in rats. Pharmazie. 2017;72(5):249–256.
- Han K, Pan X, Chen M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci. 2010;41(5):692–699.
- Chen Y, Liang X, Ma P, et al. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration. AAPS PharmSciTech. 2015;16(4):846–854.
- Abdel-Hafez SM, Hathout RM, Sammour OA. Tracking the transdermal penetration pathways of optimized curcumin-loaded chitosan nanoparticles via confocal laser scanning microscopy. Int J Biol Macromol. 2018;108:753–764.
- Gu Y, Tang X, Yang M, et al. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Int J Pharm. 2019;554:235–244.
- Chu X, Li Q, Gui S, et al. Characterization and in vitro permeation study of cubic liquid crystal containing sinomenine hydrochloride. AAPS PharmSciTech. 2018;19(5):2237–2246.
- Wan J, Wang SM, Gui ZP, et al. Phytantriol-based lyotropic liquid crystal as a transdermal delivery system. Eur J Pharm Sci. 2018;125:93–101.
- Cao JJ, Li ZG, Li Q, et al. Sinomenine liquid crystalline gel preparation and in vitro evaluation. Chin J Pharm. 2017;52(19):1691–1697.
- Wang XQ, Zhang Y, Huang J, et al. Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate. Int J Pharm. 2019;562:31–41.
- Chu XQ, Huang J, Li ZG, et al. On the structure and transdermal profile of liquid crystals based on phytantriol. Curr Drug Deliv. 2018;15(10):1439–1448.
- Mei L, Xie Y, Huang Y, et al. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia. Acta Biomater. 2018;67:99–110.
- Bitan-Cherbakovsky L, Yuli-Amar I, Aserin A, et al. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C. Langmuir. 2010;26(5):3648–3653.
- Helledi LS, Schubert L. Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system. Drug Dev Ind Pharm. 2001;27(10):1073–1081.
- Patil SS, Venugopal E, Bhat S, et al. Exploring microstructural changes in structural analogues of ibuprofen-hosted in situ gelling system and its influence on pharmaceutical performance. AAPS PharmSciTech. 2015;16(5):1153–1159.
- Unagolla JM, Jayasuriya AC. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system. Eur J Pharm Sci. 2018;114:199–209.
- Fong WK, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide ‘on-demand’ drug delivery in vitro and in vivo. J Control Release. 2009;135(3):218–226.
- Liu Q, Hu J, Whittaker MR, et al. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems. J Colloid Interface Sci. 2017;508:517–524.
- Liang X, Chen Y, Jiang X, et al. HII mesophase as a drug delivery system for topical application of methyl salicylate. Eur J Pharm Sci. 2017;100:155–162.
- Lan Y, Wu Q, Mao YQ, et al. Cytotoxicity and enhancement activity of essential oil from Zanthoxylum bungeanum Maxim. as a natural transdermal penetration enhancer. J Zhejiang Univ Sci B. 2014;15(2):153–164.
- Khurana S, Jain NK, Bedi PMS. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 2013;92(6–7):383–392.
- Zhang CF, Yang ZL, Luo JB, et al. Effects of cinnamene enhancers on transdermal delivery of ligustrazine hydrochloride. Eur J Pharm Biopharm. 2007;67(2):413–419.
- He W, Guo X, Xiao L, et al. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int J Pharm. 2009;382(1–2):234–243.
- Casal HL, Cameron DCS, Smith I, Mantsch HH. Acholeplasma laidlawii membranes: a Fourier transform infrared study to the itifluencc of protein on hpid organization and dynamics. Biochemistry. 1980;19(3):444–451.
- Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers-how do they really work. J Control Release. 2005;105(1–2):1–15.